ReviewAdvances in experimental medicine and biology2026
A Brief Introduction into the Biological Phenomenon of Cell-Cell Fusion.
Review in Advances in experimental medicine and biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Even though the merger of two (or more) cells appears simple, the whole process is rather complex and not yet fully understood. While it is clear that cell-cell fusion and virus-cell fusion depends on the expression and presence of specific fusion-relevant proteins and molecules, such as fusogens in general and their receptors, cell-cell adhesion molecules, proteases, and phospholipids like phosphatidylserine (PS), the underlying mechanisms that regulate and control cell-cell fusion still remains to be elucidated. In this regard, it is necessary to discriminate between physiological and pathophysiological cell-cell fusion processes. In physiological cell-cell merger, the fusion machinery, which is composed of all fusion-relevant proteins and molecules, is initiated in individual cells in an inherent and even evolutionarily conserved time- and development-dependent manner. The sperm and the oocyte have to fuse during fertilization, the merger of trophoblasts into multinucleated syncytiotrophoblasts is important for proper placenta formation and function, and multinucleated myofibers cannot originate without the fusion of single-nucleated myoblasts. In contrast, cell-cell fusion events that occur in adult organisms in a rather non-evolutionarily conserved manner, such as the merger of cells in tissue regeneration processes or in tumor tissues, remain ambiguous. While it is clear that the fusion machinery must be active, it is not completely understood how the merger machinery is ultimately initiated and controlled in these cells, which particularly applies to tumor cells. In fact, it is well-known that tumor cells can fuse with other normal cells, such as macrophages, fibroblasts, and stem cells, but it is completely unclear why tumor cells and normal cells do this. Is this the reactivation of probably evolutionarily conserved mechanisms that have occurred in cancer cells and normal cells, or is this purely random? And if so, does the merging of cancer cells and normal cells have any benefits for the organism, for example, by enabling the immune system to better recognize and eliminate the fused tumor cells? Or, on the other hand, does illicit tumor cell fusion compound tumor growth and evolution via genomic rewiring/reprogramming and the inheritance of genomic instability to the next generation?Thus, the aim of this book is to bring more light into the complex, tightly regulated, and fascinating process of cell-cell fusion.
Indexed as
Identifiers
42168736What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.